46 results on '"Zoheiry, Mona"'
Search Results
2. Correction: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
3. Whey protein concentrate and lactoferrin alleviated anaemia, immunotoxicity, and biochemical alterations in a mouse model of early hepatocarcinogenesis
4. Retraction Note: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
5. The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
6. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients
7. Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma
8. Hepatocellular expression of epithelial–mesenchymal transition markers in a sample of hepatitis C virus-infected Egyptian patients
9. Impact of E-cadherin and its transcription regulators on assessing epithelial-mesenchymal transition in chronic hepatitis C virus infection
10. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients
11. Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model
12. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model
13. CDH1 gene as a prognostic biomarker in HCV (genotype 4) induced hepatocellular carcinoma in the Egyptian patients
14. RETRACTED ARTICLE: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
15. Antihepatocarcinogenic activity of whey protein concentrate and lactoferrin in diethylnitrosamine‐treated male albino mice
16. Epithelial-mesenchymal transition of hepatocytes in chronic HCV Egyptian patients
17. Contribution of infiltrating monocytes to HCV-induced hepatic fibrosis and carcinogenesis: Immunohistochemical study
18. MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients
19. Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool
20. TH17 AND TREGULATORY CELLS IN TYPE2 DIABETIC NEPHROPATHY
21. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients
22. Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients
23. RETRACTED ARTICLE: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
24. Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study
25. The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patient
26. Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis
27. Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
28. Role of T Regulatory Cells in Chronic HCV Infected Egyptian Patients and Their Impact on the Response to Pegylated Interferon Therapy
29. Role of Epithelial Mesenchymaltransition in Hepatic Fibrogenesis
30. Circulating and Hepatic Fas Expression in HCV-Induced Chronic Liver Disease and Hepatocellular Carcinoma
31. New Insights in the Roadmap of Liver Fibrosis Pathogenesis
32. Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma.
33. Protective Role of Purified Cysteine Proteinases against Fasciola gigantica Infection in Experimental Animals
34. Effect of Combined Chemotherapy and Anti-inflammatory Drugs on Murine Schistosomiasis
35. Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool
36. Differential expression of cell cycle regulators in HCVinfection and related hepatocellular carcinoma
37. The use of whey protein concentrate in management of chronic hepatitis C virus – a pilot study
38. Effect of Combined Chemotherapy and Anti-inflammatory Drugs on Murine Schistosomiasis.
39. Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma.
40. Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model.
41. ROLE OF EPITHELIAL MESENCHYMAL TRANSITION IN HEPATIC FIBROGENESIS.
42. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.
43. Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.
44. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
45. A cross sectional study of hepatitis B, C, some trace elements, heavy metals, aflatoxin B1 and schistosomiasis in a rural population, Egypt.
46. Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.